Biotech

All Articles

Rivus' period 2 obesity-related cardiac arrest trial attacks endpoint

.Rivus Pharmaceuticals has plumped up the customers of its own fat-busting, muscle-sparing drug cand...

Ovid halts preclinical work, IV system after soticlestat fall short

.Ovid Rehab currently revealed last month that it was trimming back its own head count as the provid...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened a $700 million R&ampD center in the Boston ma Seaport, enhancing its own RNA a...

Boundless Biography makes 'moderate' discharges 5 months after $100M IPO

.Only five months after protecting a $one hundred million IPO, Vast Biography is presently laying of...

Halda's $126M will certainly evolve 'hold and kill' tumor medicines

.The preliminary stages of oncology R&ampD aren't short of appealing new modalities, and Halda Thera...

Lykos 'regrets' not divulging study infractions along with author

.Psychopharmacology has drawn three articles about midstage scientific trial information evaluating ...

Analysts dig into Avidity's DMD succeed, uncovering distinctions in information

.Avidity Biosciences amazed investors along with stage 1/2 data in Duchenne muscle dystrophy (DMD) F...

Actinogen's cortisol blocker fails period 2 depression study

.Actinogen Medical's cortisol blocker has actually overlooked the major endpoint of a period 2 study...

Bivictrix determines going exclusive only technique to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have actually been at the center of lots of a billion-dollar biobuc...

TPG bests up funds to $580M for assets throughout life scientific researches

.Property manager TPG, which has supported biotechs such as Sionna Therapeutics and also Santa Ana B...